4LL Stock Overview
Teladoc Health, Inc. provides virtual healthcare services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Teladoc Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.59 |
| 52 Week High | US$27.42 |
| 52 Week Low | US$12.18 |
| Beta | 0.94 |
| 1 Month Change | -9.54% |
| 3 Month Change | -32.05% |
| 1 Year Change | -48.07% |
| 3 Year Change | -91.00% |
| 5 Year Change | -75.80% |
| Change since IPO | -55.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4LL | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 1.3% | -2.5% | 0.5% |
| 1Y | -48.1% | -25.2% | 1.3% |
Return vs Industry: 4LL underperformed the German Healthcare Services industry which returned -24.3% over the past year.
Return vs Market: 4LL underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| 4LL volatility | |
|---|---|
| 4LL Average Weekly Movement | 9.2% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4LL's share price has been volatile over the past 3 months.
Volatility Over Time: 4LL's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 5,208 | Mala Murthy | www.teladochealth.com |
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Teladoc Health, Inc. Fundamentals Summary
| 4LL fundamental statistics | |
|---|---|
| Market cap | €2.17b |
| Earnings (TTM) | -€205.43m |
| Revenue (TTM) | €2.43b |
0.9x
P/S Ratio-10.2x
P/E RatioIs 4LL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4LL income statement (TTM) | |
|---|---|
| Revenue | US$2.60b |
| Cost of Revenue | US$760.03m |
| Gross Profit | US$1.84b |
| Other Expenses | US$2.06b |
| Earnings | -US$220.37m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.30 |
| Gross Margin | 70.80% |
| Net Profit Margin | -8.47% |
| Debt/Equity Ratio | 66.1% |
How did 4LL perform over the long term?
See historical performance and comparison